Imaging of Vulvar-Vaginal Tumors
PDF

Invited Review

Imaging of Vulvar-Vaginal Tumors

Turk Radiol Semin 2024;12(2):262-276 DOI: 10.4274/trs.2024.24142
,
PDF
Permissions

Abstract

Primary vulvar and vaginal tumors are rare malignancies. The most common histological subtype of both vulvar and vaginal cancers is squamous cell carcinoma. Ultrasound, computed tomography positron emission tomography, magnetic resonance imaging are used in imaging. Since treatment options may vary depending on the stage of the disease, pre-treatment imaging has become important. In this review, the imaging features of vulvar and vaginal tumors will be discussed.

Keywords: Vulvar cancer, vaginal cancer, magnetic resonance imaging

References

1

Soo MJ, Bharwani N, Rockall AG. Vagina and vulva: ımaging techniques, normal anatomy and anatomical variants. In: Hamm B, Ros PR, editors.Abdominal Imaging. Springer, Berlin, Heidelberg; 2013; 2201-10.

2

Griffin N, Grant LA, Sala E. Magnetic resonance imaging of vaginal and vulval pathology. Eur Radiol. 2008; 18: 1269-80.

3

Cobos GA, Pomeranz MK. A general approach to the evaluation and the management of vulvar disorders. Obstet Gynecol Clin North Am. 2017; 44: 321-7.

4

Eilber KS, Raz S. Benign cystic lesions of the vagina: a literature review. J Urol. 2003; 170: 717-22.

5

Shimada K, Ohashi I, Shibuya H, Tanabe F, Akashi T. MR imaging of an atypical vaginal leiomyoma. AJR Am J Roentgenol. 2002; 178: 752-4.

6

Yamashita Y, Torashima M, Takahashi M, Tanaka N, Katabuchi H, Miyazaki K, et al. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications. Radiology. 1993; 189: 721-5.

7

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-4.

8

Adams TS, Rogers LJ, Cuello MA. Cancer of the vagina: 2021 update. Int J Gynaecol Obstet. 2021; 155 (Suppl 1): 19-27.

9

Taylor MB, Dugar N, Davidson SE, Carrington BM. Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol. 2007; 62: 549-55.

10

Albuquerque KS, Zoghbi KK, Gomes NBN, Libânio BB, Souza E Silva TX, de Araújo EM, et al. Vaginal cancer: why should we care? Anatomy, staging and in-depth imaging-based review of vaginal malignancies focusing on MRI and PET/CT. Clin Imaging. 2022; 84: 65-78.

11

Tjalma WAA, Colpaert CGA. Primary vaginal adenocarcinoma of intestinal type arising from a tubulovillous adenoma. Int J Gynecol Cancer. 2006; 16:1461-5.

12

Lee LJ, Jhingran A, Kidd E, Cardenes HR, Elshaikh MA, Erickson B, et al. Acr appropriateness Criteria management of vaginal cancer. Oncology (Williston Park). 2013; 27: 1166-73.

13

Vang R, Medeiros LJ, Silva EG, Gershenson DM, Deavers M. Non-Hodgkin’s lymphoma involving the vagina: a clinicopathologic analysis of 14 patients. Am J Surg Pathol. 2000; 24: 719-25.

14

Lagoo AS, Robboy SJ. Lymphoma of the female genital tract: current status. Int J Gynecol Pathol. 2006; 25: 1-21.

15

Marcos-Figueiredo P, Moreira DSDC, Morim MG, Pereira JL, Salgado LS. When an unexpected diagnosis occurs: a vaginal premenopausal sarcoma. Rev Bras Ginecol Obstet. 2018; 40: 47-52.

16

Liu QY, Zeng YP, Lin XF, Liu ZF, Wu XF, Li HG. MRI findings in primary vaginal melanoma-a report of four cases. Clin Imaging. 2015; 39: 533-7.

17

Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract. Curr Oncol Rep. 2017; 19: 59.

18

Khurana A, Gupta G, Gupta M, Kaur M. Primary neuroendocrine carcinoma of the vagina with coexistent atypical vaginal adenosis: a rare entity. J Cancer Res Ther. 2013; 9: 328-30.

19

Rogers LJ, Cuello MA. Cancer of the vulva. Int J Gynaecol Obstet. 2018; 143 (Suppl 2): 4-13.

20

Chow L, Tsui BQ, Bahrami S, Masamed R, Memarzadeh S, Raman SS, et al. Gynecologic tumor board: a radiologist’s guide to vulvar and vaginal malignancies. Abdom Radiol (NY). 2021; 46: 5669-86.

21

Chokoeva AA, Tchernev G, Cardoso JC, Patterson JW, Dechev I, Valkanov S, et al. Vulvar sarcomas: short guideline for histopathological recognition and clinical management. Part 1. Int J Immunopathol Pharmacol. 2015; 28: 168-77.

22

Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F, et al. European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017; 27: 832-7.

23

Nikolić O, Sousa FAE, Cunha TM, Nikolić MB, Otero-García MM, Gui B, Nougaret S, et al. Vulvar cancer staging: guidelines of the European Society of Urogenital Radiology (ESUR). Insights Imaging. 2021; 12: 131.

24

Olawaiye AB, Cotler J, Cuello MA, Bhatla N, Okamoto A, Wilailak S, et al. FIGO staging for carcinoma of the vulva: 2021 revision. Int J Gynaecol Obstet. 2021; 155: 43-7.